McKinley Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,740
Closed -$30K 461
2017
Q1
$30K Sell
1,740
-2,700
-61% -$45.1K ﹤0.01% 408
2016
Q4
$75K Buy
+4,440
New +$74.1K ﹤0.01% 394

Other funds holding ANGO

McKinley Capital Management's ANGO Position: Q2 2017 in Review

McKinley Capital Management sold out of AngioDynamics (ANGO) in Q2 2017, closing a stake of 1,740 shares — an estimated $30K sold.

McKinley Capital Management first reported a position in ANGO in Q4 2016 and held it in 2 quarters. The position peaked at $75K in Q4 2016. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2017.

  • McKinley Capital Management reported no remaining AngioDynamics position as of Q2 2017 after selling out during the quarter.
  • McKinley Capital Management sold 1,740 AngioDynamics shares in Q2 2017, an estimated $30K.
  • McKinley Capital Management first reported a position in AngioDynamics in Q4 2016 and held it in 2 quarters.
  • McKinley Capital Management's AngioDynamics position peaked at $75K in Q4 2016.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2017.

Based on McKinley Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.